HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 15,840
+140 (0.89%)
Mar 20, 2026, 3:30 PM KST
-38.72% (1Y)
| Market Cap | 222.43B -41.7% |
| Revenue (ttm) | 36.10B +75.7% |
| Net Income | 472.66M |
| EPS | 34.13 |
| Shares Out | 14.04M |
| PE Ratio | 470.60 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 60,824 |
| Average Volume | 115,833 |
| Open | 15,700 |
| Previous Close | 15,700 |
| Day's Range | 15,700 - 16,100 |
| 52-Week Range | 12,500 - 28,850 |
| Beta | 0.45 |
| RSI | 51.06 |
| Earnings Date | Mar 27, 2026 |